Annual Epidemiological Report 2009 [2007 data]
This edition of the Annual Report gives special attention to vaccine-preventable diseases and immunisation programmesin the European Union (EU) and European Economic Area (EEA) countries. This edition was revised January and June 2010 and has authority over the print edition.
- Antimicrobial resistance
- Avian influenza virus
- Emerging disease
- Food- and waterborne diseases
- Healthcare-associated infections
- HIV infection
- Influenza in humans, avian origin
- Influenza in humans, seasonal
- Sexually transmitted infections
- Vaccine preventable diseases
- Vector-borne disease
Cholera - Annual Epidemiological Report for 2016
Cholera is a rare travel-associated disease in the EU/EEA. In 2016, six EU/EEA countries reported 23 laboratory-confirmed cases of cholera, which was in the range of previous years. All cases with known travel history were infected outside of Europe.
Yersiniosis - Annual Epidemiological Report for 2016
In 2016, 28 countries reported 6 918 confirmed yersiniosis cases in the EU/EEA.
Anthrax - Annual Epidemiological Report for 2016
Anthrax continues to be a rare disease in humans in Europe, with only a few cases reported every year. In 2016, two EU/EEA countries reported six laboratory-confirmed anthrax cases: Romania (5) and Spain (1). The remaining 28 reporting countries notified no cases.
Congenital toxoplasmosis – Annual Epidemiological Report for 2016
In 2016, 242 confirmed cases of congenital toxoplasmosis were reported in the EU/EEA, with France accounting for 81% of all confirmed cases due to the active screening of pregnant women. The notification rate was 6.7 cases per 100 000 live births. No seasonal pattern was observed for the disease.
Tularaemia - Annual Epidemiological Report for 2016
For 2016, 1 148 cases of tularaemia were reported in the EU/EEA, 1 096 (95%) of which were confirmed.
Shigellosis - Annual Epidemiological Report for 2016
Shigellosis is a relatively uncommon disease in the EU/EEA, but remains of concern in some countries and for some population groups. In 2016, 29 EU/EEA countries reported 5 631 confirmed shigellosis cases.